452 related articles for article (PubMed ID: 28007588)
21. Salpingectomy as a means to reduce ovarian cancer risk.
Daly MB; Dresher CW; Yates MS; Jeter JM; Karlan BY; Alberts DS; Lu KH
Cancer Prev Res (Phila); 2015 May; 8(5):342-8. PubMed ID: 25586903
[TBL] [Abstract][Full Text] [Related]
22. Surgical implications of the potential new tubal pathway for ovarian carcinogenesis.
Chene G; Rahimi K; Mes-Masson AM; Provencher D
J Minim Invasive Gynecol; 2013; 20(2):153-9. PubMed ID: 23332575
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.
Norris EJ; Zhang Q; Jones WD; DeStephanis D; Sutker AP; Livasy CA; Ganapathi RN; Tait DL; Ganapathi MK
J Pathol; 2019 Jul; 248(3):352-362. PubMed ID: 30883751
[TBL] [Abstract][Full Text] [Related]
24. Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas.
Gilks CB; Irving J; Köbel M; Lee C; Singh N; Wilkinson N; McCluggage WG
Am J Surg Pathol; 2015 Mar; 39(3):357-64. PubMed ID: 25517954
[TBL] [Abstract][Full Text] [Related]
25. Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO.
Pölcher M; Hauptmann S; Fotopoulou C; Schmalfeldt B; Meinhold-Heerlein I; Mustea A; Runnebaum I; Sehouli J
Arch Gynecol Obstet; 2015 Jul; 292(1):231-4. PubMed ID: 25914073
[TBL] [Abstract][Full Text] [Related]
26. Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube.
Dietl J
Arch Gynecol Obstet; 2014 Feb; 289(2):241-6. PubMed ID: 24100801
[TBL] [Abstract][Full Text] [Related]
27. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
28. Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma.
Howitt BE; Hanamornroongruang S; Lin DI; Conner JE; Schulte S; Horowitz N; Crum CP; Meserve EE
Am J Surg Pathol; 2015 Mar; 39(3):287-93. PubMed ID: 25581732
[TBL] [Abstract][Full Text] [Related]
29. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
30. Opportunistic salpingectomy for prevention of sporadic ovarian cancer - a jump from basic science to clinical practice?
Ziętek A; Bogusiewicz M; Szumiło J; Rechberger T
Ginekol Pol; 2016; 87(6):467-72. PubMed ID: 27418226
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?
Kotsopoulos J; Narod SA
Int J Cancer; 2020 Sep; 147(5):1245-1251. PubMed ID: 32037528
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic salpingectomy and prophylactic salpingoophorectomy for adnexal high-grade serous epithelial carcinoma: A reappraisal.
Oliver Perez MR; Magriñá J; García AT; Jiménez Lopez JS
Surg Oncol; 2015 Dec; 24(4):335-44. PubMed ID: 26690823
[TBL] [Abstract][Full Text] [Related]
33. Incidence of germline BRCA1/2 mutations in women with tubo-ovarian high-grade serous carcinomas with and without serous tubal intra-epithelial carcinomas.
Dowson CB; Stewart C; O'Sullivan S; Pachter N; Schofield L; Cohen PA
Int J Gynecol Cancer; 2020 Jan; 30(1):94-99. PubMed ID: 31699802
[TBL] [Abstract][Full Text] [Related]
34. Salpingectomy for the Risk Reduction of Ovarian Cancer: Is It Time for a Salpingectomy-alone Approach?
Boerner T; Long Roche K
J Minim Invasive Gynecol; 2021 Mar; 28(3):403-408. PubMed ID: 33038519
[TBL] [Abstract][Full Text] [Related]
35. Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO).
Stanciu PI; Ind TEJ; Barton DPJ; Butler JB; Vroobel KM; Attygalle AD; Nobbenhuis MAE
J Ovarian Res; 2019 May; 12(1):50. PubMed ID: 31128592
[TBL] [Abstract][Full Text] [Related]
36. The role of the fallopian tube in the origin of ovarian cancer.
Erickson BK; Conner MG; Landen CN
Am J Obstet Gynecol; 2013 Nov; 209(5):409-14. PubMed ID: 23583217
[TBL] [Abstract][Full Text] [Related]
37. Possible origin of ovarian cancer in the fallopian tubes.
Venkatesan P
Lancet Oncol; 2017 Dec; 18(12):e714. PubMed ID: 29103868
[No Abstract] [Full Text] [Related]
38. Genomic catastrophe, the peritoneal cavity and ovarian cancer prevention.
Yoon JY; Chapel DB; Goebel E; Qian X; Mito JK; Horowitz NS; Miron A; Soong TR; Xian W; Crum CP
J Pathol; 2022 Jul; 257(3):255-261. PubMed ID: 35238033
[TBL] [Abstract][Full Text] [Related]
39. Tips and Tricks for Performing Salpingectomy at the Time of Laparoscopic Hysterectomy.
Stuparich MA; Lee TTM
J Minim Invasive Gynecol; 2017 Feb; 24(2):205. PubMed ID: 27956107
[TBL] [Abstract][Full Text] [Related]
40. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.
Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ
J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
